Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?

This is a report on a case series of five patiens with psychosis in Parkinson's disease who were treated successfully with an intramuscular injection of ziprasidone (10–20 mg) for acute agitation. No deterioration of motor function or other clinically relevant side effects were seen. Copyright...

Full description

Saved in:
Bibliographic Details
Published in:Human psychopharmacology 2005-04, Vol.20 (3), p.203-205
Main Authors: Oechsner, Matthias, Korchounov, Alexei
Format: Article
Language:English
Subjects:
Aged
Antiparkinson Agents - therapeutic use
Antipsychotic Agents - administration & dosage
Antipsychotic Agents - adverse effects
Antipsychotic Agents - therapeutic use
Electrocardiography
Emergency Medical Services
Female
Humans
Injections, Intramuscular
Male
Middle Aged
neuroleptic
Parkinson Disease - complications
Parkinson Disease - drug therapy
Parkinson Disease - psychology
Parkinson's disease
Piperazines - administration & dosage
Piperazines - adverse effects
Piperazines - therapeutic use
Psychiatric Status Rating Scales
Psychomotor Agitation - drug therapy
Psychomotor Agitation - etiology
psychosis
Psychotic Disorders - drug therapy
Psychotic Disorders - etiology
Psychotic Disorders - psychology
Thiazoles - administration & dosage
Thiazoles - adverse effects
Thiazoles - therapeutic use
treatment
ziprasidone
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This is a report on a case series of five patiens with psychosis in Parkinson's disease who were treated successfully with an intramuscular injection of ziprasidone (10–20 mg) for acute agitation. No deterioration of motor function or other clinically relevant side effects were seen. Copyright © 2005 John Wiley & Sons, Ltd.
ISSN:0885-6222
1099-1077
DOI:10.1002/hup.682